Denny P, Lord C J, Hill N J, Goy J V, Levy E R, Podolin P L, Peterson L B, Wicker L S, Todd J A, Lyons P A
Wellcome Trust Centre for Human Genetics, University of Oxford, Headington, U.K.
Diabetes. 1997 Apr;46(4):695-700. doi: 10.2337/diab.46.4.695.
Currently, 16 loci that contribute to the development of IDDM in the NOD mouse have been mapped by linkage analysis. To fine map these loci, we used congenic mapping. Using this approach, we localized the Idd3 locus to a 0.35-cM interval on chromosome 3 containing the Il2 gene. Segregation analysis of the known variations within this interval indicated that only one variant, a serine-to-proline substitution at position 6 of the mature interleukin-2 (IL-2) protein, consistently segregates with IDDM in crosses between NOD and a series of nondiabetic mouse strains. These data, taken together with the immunomodulatory role of IL-2, provide circumstantial evidence in support of the hypothesis that Idd3 is an allelic variation of the Il2 gene, or a variant in strong linkage disequilibrium.
目前,通过连锁分析已在非肥胖型糖尿病(NOD)小鼠中定位了16个与IDDM发病相关的基因座。为了对这些基因座进行精细定位,我们采用了同源基因定位法。利用这种方法,我们将Idd3基因座定位到了3号染色体上一个包含Il2基因的0.35厘摩区间。对该区间内已知变异的分离分析表明,在NOD与一系列非糖尿病小鼠品系的杂交中,只有一个变异,即成熟白细胞介素-2(IL-2)蛋白第6位丝氨酸到脯氨酸的取代,始终与IDDM共分离。这些数据,再结合IL-2的免疫调节作用,为支持Idd3是Il2基因的等位变异或处于强连锁不平衡状态的变异这一假说提供了间接证据。